Wanjia Group Holdings Limited (HKG:0401)
Hong Kong · Delayed Price · Currency is HKD 0.0740
-0.0040 (-5.13%)
Sep 15, 2025, 3:58 PM HKT
Wanjia Group Holdings Market Cap
Wanjia Group Holdings has a market cap or net worth of 41.46 million as of September 15, 2025. Its market cap has increased by 57.45% in one year.
Market Cap
41.46M
Enterprise Value
30.85M
Revenue
161.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since October 11, 2013, Wanjia Group Holdings's market cap has decreased from 525.21M to 41.46M, a decrease of -92.11%. That is a compound annual growth rate of -19.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 41.46M | 48.00% |
| Dec 31, 2024 | 28.01M | -41.18% |
| Dec 29, 2023 | 47.62M | -40.14% |
| Dec 30, 2022 | 79.55M | -11.25% |
| Dec 31, 2021 | 89.64M | 37.93% |
| Dec 31, 2020 | 64.99M | 88.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 278.04B |
| JD Health International | 222.02B |
| Hansoh Pharmaceutical Group Company | 215.52B |
| Innovent Biologics | 167.59B |
| Sino Biopharmaceutical | 154.34B |
| WuXi Biologics | 148.25B |
| Akeso | 124.81B |
| CSPC Pharmaceutical Group | 118.33B |